EMERGENCE OF BEDAQUILINE RESISTANCE AFTER COMPLETION OF BEDAQUILINE-BASED DRUGRESISTANT TB TREATMENT: A CASE STUDY FROM SOUTH AFRICA

Cover Page


Cite item

Full Text

Abstract

.

About the authors

M. de Vos

DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University

Author for correspondence.
Email: fake@neicon.ru
South Africa

S. Ley

DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University

Email: fake@neicon.ru
South Africa

B. Derendinger

DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University

Email: fake@neicon.ru
South Africa

A. Dippenaar

DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University

Email: fake@neicon.ru
South Africa

M. Grobbelaar

DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University

Email: fake@neicon.ru
South Africa

A. Reuter

Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape Town

Email: fake@neicon.ru
South Africa

J. Daniels

Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape Town

Email: fake@neicon.ru
South Africa

S. Burns

Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

Email: fake@neicon.ru
United States

G. Theron

DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University

Email: fake@neicon.ru
South Africa

J. Posey

Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

Email: fake@neicon.ru
United States

R. Warren

DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University

Email: fake@neicon.ru
South Africa

H. Cox

Institute of Infectious Disease and Molecular Medicine and Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town

Email: fake@neicon.ru
South Africa

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 de Vos M., Ley S., Derendinger B., Dippenaar A., Grobbelaar M., Reuter A., Daniels J., Burns S., Theron G., Posey J., Warren R., Cox H.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies